Methyl (R)-3-allyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-3,4-dihydro-5-oxa-1,2a-diazaacenaphthylene-7-carboxylate

Catalog No. :
ACCYFO229
CAS No. :
2407927-70-0
Molecular Formula :
C21H23N5O4
Molecular Weight :
409.45

IUPAC Name:methyl (R)-3-allyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-3,4-dihydro-5-oxa-1,2a-diazaacenaphthylene-7-carboxylate

Methyl (R)-3-allyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-3,4-dihydro-5-oxa-1,2a-diazaacenaphthylene-7-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl (R)-3-allyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-3,4-dihydro-5-oxa-1,2a-diazaacenaphthylene-7-carboxylate
IUPAC Namemethyl (R)-3-allyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-3,4-dihydro-5-oxa-1,2a-diazaacenaphthylene-7-carboxylate
Molecular FormulaC21H23N5O4
Molecular Weight409.45
SMILESC=CC[C@@H]1COC2=CC(C(=O)OC)=CC3=C2N1C(NC(=O)C1=CC(C)=NN1CC)=N3
InChI KeyKXHNUPNKVOKKGJ-CQSZACIVSA-N
Synonym(R)-3-Allyl-2-[(2-ethyl-5-methyl-2H-pyrazole-3-carbonyl)-amino]-3,4-dihydro-5-oxa-1,2a-diaza-acenaphthylene-7-carboxylic acid methyl ester
CAS No.2407927-70-0

Synthetic Route by SureRoute

1. ACCYFO229 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAZSX298 route compound structure diagram
    ACAZSX29850920-65-5 In Stock
  4. Then
  5. ACCYFO229 route product structure diagram
    ACCYFO2292407927-70-0
Inquiry

2. ACCYFO229 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWJIE045 route compound structure diagram
    ACWJIE045128249-59-2 In Stock
  4. Then
  5. ACCYFO229 route product structure diagram
    ACCYFO2292407927-70-0
Inquiry

Comments (0)